Do cancer drugs wipe out Kids' vaccine shields? new study investigates
NCT ID NCT07422337
Summary
This study aims to understand if a common leukemia treatment called blinatumomab weakens the protection from childhood vaccines. Researchers will check antibody levels in up to 300 young patients (under 21) who have been treated for B-cell leukemia. They want to see if these patients need to be revaccinated to restore their immunity against diseases like measles, tetanus, and chickenpox.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Arkansas Children's
RECRUITINGLittle Rock, Arkansas, 72202, United States
Contact Phone: •••-•••-••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Arkansas Children's Northwest
RECRUITINGSpringdale, Arkansas, 72762, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.